alexa Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience | OMICS International | Abstract
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience

Nathalie Aladjidi1,2*, Raoul Santiago1,2, Corinne Pondarré3, Anne Lambilliotte4, Guy Leverger5, Claire Godard Sebillotte6,
Vincent Barlogis7, Pierre Rohrlich8, Marlène Pasquet9, Sophie Bayart10, Dominique Plantaz11, Patrick Lutz12, Karine de Bosredon13, Aude Marie-Cardine14, Corinne Guitton15, Patrick Boutard16, Martine Munzer17, Jean-Louis Stephan18, Thierry Leblanc19 and Y. Perel1,2

1CHU Bordeaux, Centre de Référence National des Cytopénies Auto-immunes de l’Enfant(CEREVANCE), Place Amélie Raba Léon, 33 076 Bordeaux, France

2Pediatric Hematologic Unit, University Hospital, Place Amélie Raba Léon, 33 076 Bordeaux, France

3Pediatric Hematologic Unit, University Hospital - IHOP, Lyon, 69 008 Bordeaux, France

4Pediatric Hematologic Unit, University Hospital, 59 037 Lille, France

5Pediatric Hematologic Unit, University Hospital – Trousseau – APHP, 75012 Paris, France

6INSERM/UPMC UMR-S 707, 75007 Paris, France

7Pediatric Hematologic Unit, University Hospital – APHM, 13385 Marseille, France

8Pediatric Hematologic Unit, University Hospital, 25030 Besançon, France

9Pediatric Hematologic Unit, University Hospital, 31026 Toulouse, France

10Pediatric Hematologic Unit, University Hospital, 35203 Rennes, France

11Pediatric Hematologic Unit, University Hospital, 38043 Grenoble, France

12Pediatric Hematologic Unit, University Hospital, 67098 Strasbourg, France

13Department of Nuclear Medicine, University Hospital, Place Amélie Raba Léon, 33 076 Bordeaux, France

14Pediatric Hematologic Unit, University Hospital, 76031 Rouen, France

15Pediatric Hematologic Unit, University Hospital, 94275 Le Kremelin Bicêtre, France

16Pediatric Hematologic Unit, University Hospital, 14033 Caen, France

17Pediatric Hematologic Unit, University Hospital, 51092 Reims, France

18Pediatric Hematologic Unit, University Hospital, 42055 Saint-Etienne, France

19Pediatric Hematologic Unit, University Hospital – Robert Debré – APHP, 75019 Paris, France

Corresponding Author:
Nathalie Aladjidi
Pediatric Hematology Unit
Centre de Référence National des Cytopénies Auto-immunes de l’Enfant(CEREVANCE)
Hôpital des Enfants, Hôpital Pellegrin, CHU Bordeaux
Place Amélie Raba Léon, 33 000 Bordeaux, France
Tel: 00 33 5 57 82 02 61
Fax: 00 33 5 57 82 02 79
E-mail: [email protected]

Received Date: April 20, 2012; Accepted Date: May 16, 2012; Published Date: May 22, 2012

Citation: Aladjidi N, Santiago R, Pondarré C, Lambilliotte A, Leverger G, et al. (2012) Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience. J Blood Disord Transfus S3:003. doi: 10.4172/2155-9864.S3-003

Copyright: © 2012 Aladjidi N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Objective: While splenectomy is the gold standard treatment for refractory primary immune thrombocytopenia (ITP) in adult, its place remains debated in children. The French Rare Disease Plan provided us the opportunity to conduct a collaborative study of the efficiency and tolerance of this procedure in childhood ITP.

Patients and methods: A retrospective study was conducted in France in order to identify children with ITP treated with splenectomy during a 9-year period. A total of 78 children were included. Data from the ongoing CEREVANCE national cohort of childhood auto-immune cytopenia in 30 units were reviewed and completed by a direct contact with the referent physicians. International terminology for response definition was used. Relapsefree survival was assessed by the Kaplan-Meier method.

Results: The median ages at ITP diagnosis and splenectomy were 9.6 and 12.4 years respectively. The median duration of ITP before splenectomy was 24 months (1-162); 62 children had chronic ITP. The median number of treatment lines before splenectomy was 2 (1-7). Laparoscopy was used in 81% of cases. Four children underwent immediate surgical complications. With a median follow-up of 41 months, complete remission (CR) was maintained at the latest news in 84% of children. CR was obtained in 77% of cases with intra-splenic platelets destruction, and in no case with non-splenic destruction (p=0.11). Using a very strict definition for relapse, the 5-year relapse-free survival was 51% [IC95% 37-64]. No death or overwhelming sepsis was reported.

Conclusions: In this national study with a long term follow up, the excellent benefit/risk ratio of splenectomy for refractory ITP confirms that in skilled and concerted teams, the procedure is still at the forefront of curative treatments. Isotopic evaluation is of value but other prognostic factors for CR are to be determined. Lifelong survey of potential infectious and thrombotic risk at adult age has to be coordinated by the referring physician. The place for other therapeutic options, in order to postpone as late as possible the splenectomy in childhood ITP is now to be determined.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemis[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version